Propranolol and Misoprostol Versus Misoprostol Alone for Induction of Labor in Primigravidas
1 other identifier
interventional
128
1 country
1
Brief Summary
To compare propranolol and misoprostol versus misoprostol alone for induction of labour in primigravidas
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Feb 2020
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2020
CompletedFirst Submitted
Initial submission to the registry
August 26, 2020
CompletedFirst Posted
Study publicly available on registry
September 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 13, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 15, 2020
CompletedAugust 31, 2022
August 1, 2022
8 months
August 26, 2020
August 30, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Induction delivery interval
The time from starting induction to the delivery
procedure delivery
Secondary Outcomes (1)
Mode of delivery
delivery
Study Arms (2)
Misoprostol + propranolol
ACTIVE COMPARATORPatient who receive misoprostol then after 30minutes receive propranolol
Misoprostol + placebo
PLACEBO COMPARATORPt who will receive misoprostol then after 30minutes receive placebo
Interventions
Pt will receive misoprostol for labor induction then after 30 minutes will receive ether propranolol or misoprostol
Eligibility Criteria
You may qualify if:
- Primigravidas.
- Full term patients with ultrasound confirmed dates.
- Singleton.
- Cephalic presentation.
- Fetal heart rate between 120 to 160 beats per minute.
You may not qualify if:
- Any history of previous surgery on the uterus.
- Patients in active labour, with ruptured membranes.
- Fetal distress.
- Macrosomia or polyhydramnios
- Hypersensitivity to prostaglandins.
- Asthmatic patient .
- liver or kidney impairment .
- known cardiac patient with abnormal ECG.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ahmed mohamed fathy ismaillead
- Ain Shams Universitycollaborator
Study Sites (1)
Ahmed mohamed fathy ismail
Zagazig, El Sharquia, 055, Egypt
Related Publications (1)
Abdel Hamid AS, El Zeneiny H, Fathy A, Nawara M. A pilot study to compare propranolol and misoprostol versus misoprostol and placebo for induction of labor in primigravidae; a randomized, single-blinded, placebo-controlled trial. BMC Pregnancy Childbirth. 2023 Apr 4;23(1):226. doi: 10.1186/s12884-023-05537-1.
PMID: 37016326DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Ahmed S Abd El hamid, A.professor
Ain Shams University
- STUDY DIRECTOR
Hazem A Hassan elzeneiny, Professor
Ain Shams University
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Double blinded research
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
August 26, 2020
First Posted
September 1, 2020
Study Start
February 1, 2020
Primary Completion
September 13, 2020
Study Completion
September 15, 2020
Last Updated
August 31, 2022
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, CSR
- Time Frame
- September 2020
- Access Criteria
- Researchers
Study results will be available